Obiettivo The overall objective of this European project is to offer a new means of treating chronic pain and inflammation of the locomotors system. It is expected to clarify the neuronal mechanisms of degenerative disease and to provide a new generation of upload drugs with analgesic and immunosuppressive properties acting selectively in the periphery with a minimum of side effects. The project is expected to offer a therapeutic alternative with general applicability in age-related disorders such as osteoarthrosis, and skeletal metastasis as well as other chronic diseases including rheumatoid arthritis, fibromyalgia and low back pain and also reduce the need surgery. Campo scientifico medical and health sciencesclinical medicinerheumatologymedical and health sciencesclinical medicinesurgery Programma(i) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Argomento(i) 1.1.1.-6. - Key action The Ageing Population and Disabilities Invito a presentare proposte Data not available Meccanismo di finanziamento CSC - Cost-sharing contracts Coordinatore KAROLINSKA INSTITUTE Contributo UE Nessun dato Indirizzo Solnavagen 1 104 01 171 76 Stockholm Svezia Mostra sulla mappa Costo totale Nessun dato Partecipanti (4) Classifica in ordine alfabetico Classifica per Contributo UE Espandi tutto Riduci tutto INSTITUTE OF PHARMACOLOGY - POLISH ACADEMY OF SCIENCES Polonia Contributo UE Nessun dato Indirizzo Smetna str. 12 31 334 KRAKOW Mostra sulla mappa Costo totale Nessun dato INSTITUTE OF PLANT BIOCHEMISTRY Germania Contributo UE Nessun dato Indirizzo Weinberg 3 06120 HALLE (SAALE) Mostra sulla mappa Costo totale Nessun dato LEOPOLD-FRANZENS-UNIVERSITAET INNSBRUCK Austria Contributo UE Nessun dato Indirizzo Innrain 52 a 6020 INNSBRUCK Mostra sulla mappa Costo totale Nessun dato SEMMELWEIS UNIVERSITY OF MEDICINE Ungheria Contributo UE Nessun dato Indirizzo Puskin 9 1088 BUDAPEST Mostra sulla mappa Costo totale Nessun dato
